about
Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosisMicroRNA dysregulation in diabetic ischemic heart failure patientsThe possible mechanisms underlying the impairment of HIF-1α pathway signaling in hyperglycemia and the beneficial effects of certain therapiesFibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markersIntimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy.Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformationDiabetic complications within the context of aging: Nicotinamide adenine dinucleotide redox, insulin C-peptide, sirtuin 1-liver kinase B1-adenosine monophosphate-activated protein kinase positive feedback and forkhead box O3Hyperglycemic Stress and Carbon Stress in Diabetic GlucotoxicityRoles of Pyruvate, NADH, and Mitochondrial Complex I in Redox Balance and Imbalance in β Cell Function and DysfunctionRedox implications in adipose tissue (dys)function--A new look at old acquaintancesBiomedical implications of heavy metals induced imbalances in redox systemsAssessment of the cardiovascular and gastrointestinal autonomic complications of diabetesERK5 Mediated Signalling in Diabetic RetinopathyStreptozotocin-induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic β cell glucotoxicityDeclining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during agingA hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular diseaseObesity and Diabetic Kidney Disease: Role of Oxidant Stress and Redox BalanceThe association of systemic microvascular changes with lung function and lung density: a cross-sectional studyProtective mechanisms of mitochondria and heart function in diabetesBiochemical issues in estimation of cytosolic free NAD/NADH ratioRetinal insulin receptor signaling in hyperosmotic stressProteomics and systems biology for understanding diabetic nephropathyCharacterization of hearing loss in aged type II diabeticsEndothelial mitochondria--less respiration, more integration.Microcirculatory effects of KATP channel blockade by sulphonylurea derivatives in humans.Heme oxygenase-1 protects retinal endothelial cells against high glucose- and oxidative/nitrosative stress-induced toxicity.Polyol-pathway-dependent disturbances in renal medullary metabolism in experimental insulin-deficient diabetes mellitus in rats.Therapeutic implications of curcumin in the prevention of diabetic retinopathy via modulation of anti-oxidant activity and genetic pathways.Effects of nitric oxide synthase inhibitor on intraocular pressure and ocular inflammation following laser irradiation in rabbits.From molecular footprints of disease to new therapeutic interventions in diabetic nephropathy.Two-week treatment with pravastatin improves ventriculo-vascular haemodynamic interactions in young men with type 1 diabetes.Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.Molecular mechanisms of diabetic vascular complicationsGlucose-induced metabolic memory in Schwann cells: prevention by PPAR agonists.Polyol pathway and diabetic nephropathy revisited: Early tubular cell changes and glomerulopathy in diabetic mice overexpressing human aldose reductaseAltered retinoic acid metabolism in diabetic mouse kidney identified by O isotopic labeling and 2D mass spectrometry.Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities.An update on the role of free radicals and antioxidant defense in human disease.Vascular function in Type 2 diabetes mellitus and pre-diabetes: the case for intrinsic endotheiopathy.Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.
P2860
Q24564718-4974889A-6ABC-497D-BFBF-A5EBA859E8D3Q24618462-88E74CAF-D787-4BB7-9FA1-35148072711AQ24630072-A073BA8C-7710-4483-BD68-2710E5A11BABQ24644869-C297EB5B-8981-4E40-B438-B162EA524C41Q24796491-22307722-7B62-425A-A8FC-E9DF9865F452Q24799326-AA37BE5E-B2A2-4BFF-9C67-ECBE7490DE40Q26749486-B51C72EF-5843-4E1A-8760-496CC7141983Q26773988-1D77DD0C-6E20-49D2-AD8B-8B6B790197FEQ26777039-DD310DEE-4318-451B-92E4-C9DB7300A8E8Q26801347-6E4AE543-7A10-4A87-AC30-EC7A830DDB65Q27004691-C190E3D7-60EA-4814-9A4E-44FFFD46EECEQ28077101-2199D1D5-BACB-4EC6-9C96-E3137AFF87DDQ28083251-6741C3E9-272A-405D-AE5D-5BFEBA11871AQ28260875-35E902AE-2CB0-4957-B37B-A420228637DEQ28304473-30AAD464-3191-4295-AD6A-2F5B0341ED1EQ28361892-9F8DFDF7-CE88-4D0E-A4CE-2ABD6FE068EEQ28385322-F5B9F17F-14A0-43C2-92B6-033F6FD9DB37Q28392241-48C368D8-CF52-4CE6-AB00-518E3ACB7219Q28395215-FA9DA788-BAB7-47B4-8747-A510E2D668FCQ28483254-03EA8872-B3F4-49CC-B5A6-E2BB210D9A67Q28568662-A5F46AF9-B220-4E52-BDFE-4BE855524DC3Q28728631-AFB57182-8CCD-44A4-B90B-62B111509AB9Q30486612-B8A88DE4-F35C-4E89-B4B8-271D195106DEQ30519471-9000FE0B-C229-4752-9168-25F5A1782B52Q30827252-BAD54BDE-D94A-4F67-832A-DE0E20E2A6ECQ31083347-52A65B7E-F493-4024-9FB5-531E810BA069Q31087420-EFDBE1DC-1F14-4251-84AD-5FC902564D98Q31146840-A913A33C-D46F-48DE-A237-C7293DBC2500Q32067895-C3FEBF08-4CDD-4797-91AF-E571B116AE0EQ33220108-8D41E728-AF61-4E4B-8285-75BFA82AD0AEQ33283202-5EAC136B-F114-4008-8648-16AF54E1D64EQ33530824-0556738E-201D-459D-AFCD-8EFF124EDC47Q33558421-F75F66A0-F25E-4D12-BEFF-598A151B5B31Q33569693-E7AD702C-47C6-45F4-BDFF-8F37BE93A21DQ33588307-54AFAAA9-4348-4EEB-885C-BA3683E6B891Q33608656-C4019A0E-F4C1-4C42-8EC9-81AC61E816EBQ33668501-E28D1EF1-5FE2-487A-9289-773FFA0958B1Q33704711-774D8016-B0C1-4447-BF49-B9B350B1215BQ33746382-606DE7D3-0E8D-4598-8382-078382BDCF0AQ33793187-D18DE20F-6A31-42F9-B2F2-7098DEC03B01
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Hyperglycemic pseudohypoxia and diabetic complications.
@en
type
label
Hyperglycemic pseudohypoxia and diabetic complications.
@en
prefLabel
Hyperglycemic pseudohypoxia and diabetic complications.
@en
P2093
P356
P1433
P1476
Hyperglycemic pseudohypoxia and diabetic complications
@en
P2093
J R Nyengaard
J R Williamson
M van den Enden
R G Tilton
T Kawamura
P304
P356
10.2337/DIAB.42.6.801
P407
P50
P577
1993-06-01T00:00:00Z